Quanticel Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Quanticel Pharmaceuticals Ownership

Who owns Quanticel Pharmaceuticals?

Quanticel Pharmaceuticals is owned by Celgene. It was acquired on April 27, 2015.

Quanticel Pharmaceuticals Business Overview

Where is Quanticel Pharmaceuticals headquartered?

Quanticel Pharmaceuticals is headquartered in San Francisco, California.

What sector is Quanticel Pharmaceuticals in?

Quanticel Pharmaceuticals is a life science company.

When was Quanticel Pharmaceuticals founded?

Quanticel Pharmaceuticals was founded in 2009.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Quanticel Pharmaceuticals, Inc.

1500 Owens Street, Suite 500,
San Francisco, California 94158
United States,
(415) 358 7609
www.quanticel.com

Quanticel Pharmaceuticals, Inc. is a private drug discovery company committed to creating breakthrough medicines for the treatment of cancer. Quanticel’s proprietary platform for the single-cell genomic analysis of human cancer is based on the work of company founders and Stanford professors Stephen Quake and Michael Clarke.


 Subscribe to unlock this and 202,135
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.